In related work (Monaco-Kushner-in submission), we reported that the frequency of EBV detection in CD19 + cells in AMS was twice that of the HC and SMS groups, providing further evidence for increased EBV replication during clinical relapse in MS. This evidence concerns the gene CD19 and myeloid sarcoma.